POMALYST for Myelofibrosis: Side Effects & Safety Data
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
There are 5 adverse event reports in the FDA FAERS database where POMALYST was used for Myelofibrosis.
Most Reported Side Effects for POMALYST
| Side Effect | Reports | % | Deaths | Hosp. |
|---|---|---|---|---|
| Death | 177 | 12.7% | 177 | 17 |
| Plasma cell myeloma | 162 | 11.6% | 105 | 36 |
| Pneumonia | 98 | 7.0% | 17 | 80 |
| Fatigue | 94 | 6.7% | 1 | 7 |
| Full blood count decreased | 51 | 3.7% | 3 | 25 |
| Dyspnoea | 47 | 3.4% | 1 | 21 |
| Dizziness | 38 | 2.7% | 0 | 2 |
| Neuropathy peripheral | 37 | 2.7% | 0 | 2 |
| Rash | 36 | 2.6% | 0 | 7 |
| Asthenia | 35 | 2.5% | 3 | 10 |
| Pyrexia | 35 | 2.5% | 1 | 18 |
| Adverse drug reaction | 34 | 2.4% | 0 | 1 |
| White blood cell count decreased | 34 | 2.4% | 1 | 9 |
| Drug ineffective | 32 | 2.3% | 4 | 10 |
| Unevaluable event | 32 | 2.3% | 3 | 2 |
Other Indications for POMALYST
Other Drugs Used for Myelofibrosis
RUXOLITINIB (21,650)
PACRITINIB (1,586)
JAKAFI (1,314)
FEDRATINIB (682)
MOMELOTINIB (526)
LENALIDOMIDE (496)
THALIDOMIDE (349)
DEFERASIROX (150)
HYDROXYUREA (129)
JAKAVI (98)